MELNĀ PIEKTDIENA20 % ATLAIDE VISAMPiegāde ES teritorijā tajā pašā dienāAKCIJA BEIDZAS 30. NOVEMBRĪ

What Is CJC-1295 With DAC? Albumin-Binding GHRH Analogue Research Overview

Laboratorijas rokasgrāmata · Augšanas hormona ass

What Is CJC-1295 With DAC? Albumin-Binding GHRH Analogue Research Overview

What is CJC-1295 With DAC? It is a growth hormone-releasing hormone analogue carrying a drug affinity complex, a maleimide group that bonds covalently to serum albumin and extends its time in circulation to days. This guide explains that chemistry, the published pharmacokinetic findings, and how the compound differs from the no-DAC form.

Baltic Peptides laboratorijas komandaLasīšanas laiks: 8 minūtesAtjaunots 2026. gada 22. novembrī

Bieži uzdotie jautājumi

Bieži uzdotie jautājumi

What is CJC-1295 With DAC?
A tetrasubstituted GHRH(1-29) analogue with a maleimide-bearing lysine at the C terminus that bonds to serum albumin, giving it a duration of action measured in days.
What does the drug affinity complex do?
The maleimide reacts with the free thiol of cysteine-34 on albumin to form a stable thioether bond, so the peptide circulates as an albumin conjugate and is cleared more slowly.
What is the half-life of CJC-1295 With DAC?
A study abstract by Ionescu and Frohman gives a half-life of about 8 days for the albumin-bound compound, and Baltic Peptides cites 5.8 to 8.1 days for the Teichman study of healthy adults.
What did the 2006 human study find?
After a single injection, mean GH rose 2- to 10-fold for six days or more and mean IGF-I rose 1.5- to 3-fold for 9 to 11 days, and the authors described it as safe and relatively well tolerated at the doses tested.
Does CJC-1295 With DAC change GH pulsatility?
Pulse frequency and magnitude were unaltered in the Ionescu and Frohman study, but trough GH levels rose about 7.5-fold, which raised overall GH secretion.
How is CJC-1295 With DAC different from CJC-1295 No DAC?
The DAC version binds albumin and lasts days, while the no-DAC peptide lacks the maleimide group and is short-acting. They are different molecules with different masses.
Is CJC-1295 With DAC an approved medicine?
No. It has no EMA or FDA approval, and earlier clinical studies do not change its research-only status. Baltic Peptides supplies it for laboratory research only.

Lasiet tālāk

Ieteicamā literatūra

CJC-1295 ar DAC

Current batches, formats and the COA for CJC-1295 With DAC.

Kas ir CJC-1295 bez DAC?

The short-acting peptide without the albumin-binding group.

Paskaidrojums par peptīdu maisījumiem

Kāpēc komponentu pētījumi nenosaka kombinēto sastāvu?

Research-grade CJC-1295 With DAC, tested before it ships

Neatkarīgie „ HPLC ” un masu spektrometrijas rezultāti katrai partijai, kas tiek nosūtīta no ES.

Atstāj komentāru

Jūsu e-pasta adrese netiks publicēta. Obligātie lauki ir atzīmēti ar *

Iepirkumu grozs
0